• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“静宁颗粒”可通过调节多巴胺能D2/D1样受体介导的信号通路减轻大鼠注意力缺陷多动障碍。

"Jing-Ning Granules" Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways.

作者信息

Ding Jie, Ding Yiyun, Wu Jingjing, Deng Jialin, Yu Qingyang, Wang Junhong

机构信息

Department of Pediatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.

School of Psychology, Capital Normal University, Beijing 100048, China.

出版信息

Evid Based Complement Alternat Med. 2022 Oct 28;2022:9139841. doi: 10.1155/2022/9139841. eCollection 2022.

DOI:10.1155/2022/9139841
PMID:36337583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9635972/
Abstract

BACKGROUND

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficit, hyperactivity, and impulsivity. Jing-Ning Granules (JNG) is a traditional Chinese medicine (TCM) that can alleviate ADHD. Although JNG is commonly used for the effective treatment of ADHD and has obtained the national invention patent, the exact mechanism of action remains unclear.

OBJECTIVE

In this study, we examined the effect and mechanism of JNG in spontaneously hypertensive rats (SHRs). We hypothesized that JNG affects dopaminergic D2/D1-like receptors and related pathways.

MATERIALS AND METHODS

Six rat groups were used in the experiment: Wistar-Kyoto rats (WKY, control group) and five SHR groups, including a model group; atomoxetine (ATX, positive control) group; and low, medium, and high-dose JNG groups. The corresponding treatments were daily administered to each group for 6 weeks. A behavioral test, including a step-down test and open field test (OFT), was carried out at the end of treatment. After the behavioral test, all animals were sacrificed, and the brain tissue was collected and analyzed ex vivo; histopathological analysis was performed to assess the pathological changes of the hippocampus; expression of D1-like and D2-like receptors, sensor protein calmodulin (CaM), protein kinase A (PKA), and calcium/calmodulin-dependent serine/threonine protein kinase (CaMKII) in the striatum and hippocampus was measured by western blot and real-time quantitative PCR (RT-PCR); cyclic adenosine monophosphate (cAMP) levels in the striatum were analyzed using an enzyme-linked immunosorbent assay (ELISA), while the level of Ca in the striatum was analyzed by a calcium kit.

RESULTS

Our results showed that ATX or JNG could ameliorate the hyperactive/impulsive behavior and cognitive function of ADHD by promoting neuroprotection. Mechanistically, ATX or JNG could prompt the expressions of Dl-like and D2-like receptors and improve the mRNA and protein levels of cAMP/PKA and Ca/CAM/CAMKII signaling pathways.

CONCLUSION

These results indicate that JNG can produce therapeutic effects by regulating the balance of D2/D1-like receptor-mediated cAMP/PKA and Ca/CaM/CaMKII signaling pathways.

摘要

背景

注意力缺陷多动障碍(ADHD)是一种以注意力缺陷、多动和冲动为特征的神经发育障碍。静宁颗粒(JNG)是一种能缓解ADHD的中药。尽管JNG通常用于有效治疗ADHD并已获得国家发明专利,但其确切作用机制仍不清楚。

目的

在本研究中,我们研究了JNG对自发性高血压大鼠(SHR)的作用及其机制。我们假设JNG会影响多巴胺能D2/D1样受体及相关通路。

材料与方法

实验使用了六个大鼠组:Wistar-Kyoto大鼠(WKY,对照组)和五个SHR组,包括一个模型组;托莫西汀(ATX,阳性对照组);以及低、中、高剂量JNG组。每组每天给予相应治疗,持续6周。治疗结束时进行行为测试,包括跳台试验和旷场试验(OFT)。行为测试后,处死所有动物,收集脑组织并进行离体分析;进行组织病理学分析以评估海马体的病理变化;通过蛋白质印迹法和实时定量PCR(RT-PCR)测量纹状体和海马体中D1样和D2样受体、传感蛋白钙调蛋白(CaM)、蛋白激酶A(PKA)以及钙/钙调蛋白依赖性丝氨酸/苏氨酸蛋白激酶(CaMKII)的表达;使用酶联免疫吸附测定(ELISA)分析纹状体中环磷酸腺苷(cAMP)水平,同时用钙试剂盒分析纹状体中的钙水平。

结果

我们的结果表明,ATX或JNG可通过促进神经保护改善ADHD的多动/冲动行为和认知功能。从机制上讲,ATX或JNG可促使D1样和D2样受体的表达,并提高cAMP/PKA和Ca/CAM/CAMKII信号通路的mRNA和蛋白质水平。

结论

这些结果表明,JNG可通过调节D2/D1样受体介导的cAMP/PKA和Ca/CaM/CaMKII信号通路的平衡产生治疗作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ba9c07cd0ca1/ECAM2022-9139841.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ad2281e7b214/ECAM2022-9139841.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ddd51aafe8a0/ECAM2022-9139841.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/362c89c272d3/ECAM2022-9139841.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/8c57c7b2d712/ECAM2022-9139841.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/c97903d0dcb4/ECAM2022-9139841.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/7bced0d43f7e/ECAM2022-9139841.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/3c95f42c6115/ECAM2022-9139841.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/a3cc042fed00/ECAM2022-9139841.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/706d9c90ad97/ECAM2022-9139841.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/34a312e02c6c/ECAM2022-9139841.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ba9c07cd0ca1/ECAM2022-9139841.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ad2281e7b214/ECAM2022-9139841.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ddd51aafe8a0/ECAM2022-9139841.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/362c89c272d3/ECAM2022-9139841.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/8c57c7b2d712/ECAM2022-9139841.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/c97903d0dcb4/ECAM2022-9139841.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/7bced0d43f7e/ECAM2022-9139841.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/3c95f42c6115/ECAM2022-9139841.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/a3cc042fed00/ECAM2022-9139841.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/706d9c90ad97/ECAM2022-9139841.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/34a312e02c6c/ECAM2022-9139841.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8b/9635972/ba9c07cd0ca1/ECAM2022-9139841.011.jpg

相似文献

1
"Jing-Ning Granules" Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways.“静宁颗粒”可通过调节多巴胺能D2/D1样受体介导的信号通路减轻大鼠注意力缺陷多动障碍。
Evid Based Complement Alternat Med. 2022 Oct 28;2022:9139841. doi: 10.1155/2022/9139841. eCollection 2022.
2
Network pharmacology, molecular docking, and experimental validation to explore the potential mechanism of Long Mu Qing Xin mixture for the treatment of attention deficit hyperactivity disorder.运用网络药理学、分子对接和实验验证来探究龙牡清心合剂治疗注意力缺陷多动障碍的潜在机制。
Front Pharmacol. 2023 Mar 17;14:1144907. doi: 10.3389/fphar.2023.1144907. eCollection 2023.
3
Long Mu Qing Xin mixture improves behavioral performance in spontaneously hypertensive rats (SHR/NCrl) by upregulating catecholamine neurotransmitters in prefrontal cortex and striatum via DRD1/cAMP/PKA-CREB signaling pathway.龙牡清心合剂通过DRD1/cAMP/PKA-CREB信号通路上调前额叶皮质和纹状体中的儿茶酚胺神经递质,改善自发性高血压大鼠(SHR/NCrl)的行为表现。
Front Pharmacol. 2024 Jul 4;15:1387359. doi: 10.3389/fphar.2024.1387359. eCollection 2024.
4
Serotonergic and Adrenergic Neuroreceptor Manipulation Ameliorates Core Symptoms of ADHD through Modulating Dopaminergic Receptors in Spontaneously Hypertensive Rats.通过调节自发性高血压大鼠多巴胺受体,5-羟色胺能和肾上腺素能神经受体操作改善 ADHD 的核心症状。
Int J Mol Sci. 2024 Feb 15;25(4):2300. doi: 10.3390/ijms25042300.
5
Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).托莫西汀对注意力缺陷多动障碍(ADHD)动物模型多动症状的影响。
PLoS One. 2014 Oct 1;9(10):e108918. doi: 10.1371/journal.pone.0108918. eCollection 2014.
6
Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.内侧前额叶皮质中异常的钙调蛋白激酶II活性与注意力缺陷多动障碍模型大鼠的认知功能障碍有关。
Brain Res. 2014 Apr 4;1557:90-100. doi: 10.1016/j.brainres.2014.02.025. Epub 2014 Feb 19.
7
Downregulation of Dopamine D1-like Receptor Pathways of GABAergic Interneurons in the Anterior Cingulate Cortex of Spontaneously Hypertensive Rats.自发性高血压大鼠扣带回前部皮层 GABA 能中间神经元多巴胺 D1 样受体途径下调。
Neuroscience. 2018 Dec 1;394:267-285. doi: 10.1016/j.neuroscience.2018.10.039. Epub 2018 Oct 28.
8
The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.自发性高血压大鼠用于模拟注意力缺陷多动障碍(ADHD)的效用,可能可由大脑中多巴胺相关基因的差异表达来解释。
Neurochem Int. 2007 May;50(6):848-57. doi: 10.1016/j.neuint.2007.02.005. Epub 2007 Mar 1.
9
Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.哌醋甲酯使注意力缺陷多动障碍混合型动物模型中升高的多巴胺转运体密度正常化,但在注意力缺陷多动障碍不伴多动冲动型中则不能达到相同程度。
Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.
10
Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.在丰富环境中饲养可减轻自发性高血压大鼠(一种注意力缺陷多动障碍动物模型)的多动和注意力不集中症状。
Physiol Behav. 2016 Mar 1;155:30-7. doi: 10.1016/j.physbeh.2015.11.035. Epub 2015 Nov 30.

引用本文的文献

1
Modulating Multiple Molecular Trajectories by Nutraceuticals and/or Physical Activity in Attention-Deficit/Hyperactivity Disorder (ADHD)-Like Behaviors in Rat Pups.通过营养保健品和/或体育活动调节幼鼠注意力缺陷/多动障碍(ADHD)样行为中的多种分子轨迹
J Neuroimmune Pharmacol. 2025 Mar 18;20(1):27. doi: 10.1007/s11481-025-10188-4.
2
Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling.通过转录组分析在半侧帕金森病大鼠模型中鉴定与海马功能障碍相关的候选基因。
Anim Cells Syst (Seoul). 2024 Apr 30;28(1):198-215. doi: 10.1080/19768354.2024.2348671. eCollection 2024.
3

本文引用的文献

1
Metabolic Activation of Atomoxetine Mediated by Cytochrome P450 2D6.阿托西汀的细胞色素 P450 2D6 介导的代谢激活。
Chem Res Toxicol. 2021 Sep 20;34(9):2135-2144. doi: 10.1021/acs.chemrestox.1c00216. Epub 2021 Aug 25.
2
Long-term medication for ADHD and development of cognitive functions in children and adolescents.ADHD 儿童和青少年的长期药物治疗与认知功能发展。
J Psychiatr Res. 2021 Oct;142:204-209. doi: 10.1016/j.jpsychires.2021.07.055. Epub 2021 Aug 2.
3
Prevalence of criminal convictions in Norwegian adult ADHD outpatients and associations with ADHD symptom severity and emotional dysregulation.
Network pharmacology, molecular docking, and experimental validation to explore the potential mechanism of Long Mu Qing Xin mixture for the treatment of attention deficit hyperactivity disorder.
运用网络药理学、分子对接和实验验证来探究龙牡清心合剂治疗注意力缺陷多动障碍的潜在机制。
Front Pharmacol. 2023 Mar 17;14:1144907. doi: 10.3389/fphar.2023.1144907. eCollection 2023.
挪威成年 ADHD 门诊患者犯罪记录的流行情况及其与 ADHD 症状严重程度和情绪失调的关系。
BMC Psychiatry. 2021 May 3;21(1):226. doi: 10.1186/s12888-021-03223-0.
4
The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.钙/钙调蛋白依赖性激酶 II 和 IV 作为神经退行性和神经精神疾病的治疗靶点。
Int J Mol Sci. 2021 Apr 21;22(9):4307. doi: 10.3390/ijms22094307.
5
Polygenic Scores for ADHD: A Meta-Analysis.多基因 ADHD 评分:一项荟萃分析。
Res Child Adolesc Psychopathol. 2021 Mar;49(3):297-310. doi: 10.1007/s10802-021-00774-4. Epub 2021 Jan 25.
6
Animal models of attention-deficit hyperactivity disorder (ADHD).注意缺陷多动障碍(ADHD)动物模型。
Int J Dev Neurosci. 2021 Apr;81(2):107-124. doi: 10.1002/jdn.10089. Epub 2021 Jan 23.
7
Biochemical characterization of four splice variants of mouse Ca2+/calmodulin-dependent protein kinase Iδ.鼠钙/钙调蛋白依赖性蛋白激酶 Iδ 四种剪接变体的生化特性。
J Biochem. 2021 Apr 29;169(4):445-458. doi: 10.1093/jb/mvaa117.
8
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.屈昔多巴改变多巴胺能神经元和前额叶皮层的活动,改善大鼠的注意缺陷/多动障碍样行为。
Eur J Pharmacol. 2021 Feb 5;892:173826. doi: 10.1016/j.ejphar.2020.173826. Epub 2020 Dec 19.
9
The neurodevelopmental role of dopaminergic signaling in neurological disorders.多巴胺能信号在神经发育障碍中的作用。
Neurosci Lett. 2021 Jan 10;741:135540. doi: 10.1016/j.neulet.2020.135540. Epub 2020 Dec 2.
10
Approach to diagnosis and management of childhood attention deficit hyperactivity disorder.儿童注意力缺陷多动障碍的诊断与管理方法
Can Fam Physician. 2020 Oct;66(10):732-736.